Inflammatory Mediators Released by Complement-derived Peptides

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1983 Aug 1

PMID 6416038

Citations 3

Authors

H Bult

A G Herman

Affiliations

Soon will be listed here.

Citing Articles

A low molecular weight proinflammatory factor from rat spleen lymphocytes. Isolation and partial characterization.

de Castro Franca S, Correa M, dos Santos Schivo I, Garcia Leme J, Giglio J Inflammation. 2007; 30(3-4):87-96.

PMID: 17473967 DOI: 10.1007/s10753-007-9024-4.

The modulation of peritoneal macrophage chemiluminescence by acute pleural inflammation, prostanoids and cyclo/lipoxygenase inhibitors.

Bird J, Tissot M, Giroud J Agents Actions. 1985; 17(2):184-91.

PMID: 3938180 DOI: 10.1007/BF01966590.

In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).

Etievant M, Leluc B, David B Agents Actions. 1988; 24(1-2):137-44.

PMID: 3261498 DOI: 10.1007/BF01968092.

References

Betz S, Henson P . Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil. J Immunol. 1980; 125(6):2756-63. View

Hartung H, HADDING U . Complement components in relation to macrophage function. Agents Actions. 1983; 13(5-6):415-28. DOI: 10.1007/BF02176404. View

Semeraro N, Colucci M, Vermylen J . Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets. Thromb Haemost. 1979; 41(2):392-406. View

Camussi G, Mencia-Huerta J, Benveniste J . Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytes and basophils. Immunology. 1977; 33(4):523-34. PMC: 1445400. View

Hartman Jr C, Glovsky M . Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release. Int Arch Allergy Appl Immunol. 1981; 66(3):274-81. DOI: 10.1159/000232831. View

Apps M, Cater D . Production of histamine-like and prostaglandin-like substances from serum incubated with rat, dog, mouse or human tumours. Br J Exp Pathol. 1973; 54(2):203-21. PMC: 2072573. View

Goetzl E, Weller P, Sun F . The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol. 1980; 124(2):926-33. View

Moncada S, Vane J . Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978; 30(3):293-331. View

McCord J, Fridovich I . The biology and pathology of oxygen radicals. Ann Intern Med. 1978; 89(1):122-7. DOI: 10.7326/0003-4819-89-1-122. View

10.

Bach M, Brashler J, MORTON D, Steel L, Kaliner M, Hugli T . Formation of leukotrienes C and D and Pharmacologic modulation of their synthesis. Adv Prostaglandin Thromboxane Leukot Res. 1982; 9:103-14. View

11.

Pinckard R, Halonen M, Palmer J, Butler C, Shaw J, Henson P . Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol. 1977; 119(6):2185-93. View

12.

Christian F, Gordon J . Platelet function in C6-deficient rabbits. Aggregation and secretion induced by collagen and zymosan. Immunology. 1975; 29(1):131-41. PMC: 1445858. View

13.

Henson P, Cochrane C . Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. J Exp Med. 1969; 129(1):167-84. PMC: 2138595. DOI: 10.1084/jem.129.1.167. View

14.

Polley M, Nachman R . The human complement system in thrombin-mediated platelet function. J Exp Med. 1978; 147(6):1713-26. PMC: 2184322. DOI: 10.1084/jem.147.6.1713. View

15.

Macintyre D, Allen A, THORNE K, GLAUERT A, Gordon J . Endotoxin-induced platelet aggregation and secretion. I. Morphological changes and pharmacological effects. J Cell Sci. 1977; 28:211-23. DOI: 10.1242/jcs.28.1.211. View

16.

Wedmore C, Williams T . Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981; 289(5799):646-50. DOI: 10.1038/289646a0. View

17.

de Clerck F, David J . Pharmacological control of platelet and red blood cell function in the microcirculation. J Cardiovasc Pharmacol. 1981; 3(6):1388-412. DOI: 10.1097/00005344-198111000-00026. View

18.

Linder B, Chernoff A, Kaplan K, Goodman D . Release of platelet-derived growth factor from human platelets by arachidonic acid. Proc Natl Acad Sci U S A. 1979; 76(8):4107-11. PMC: 383987. DOI: 10.1073/pnas.76.8.4107. View

19.

JACOB H . Complement-induced vascular leukostasis. Its role in tissue injury. Arch Pathol Lab Med. 1980; 104(12):617-20. View

20.

Stimler N, Bloor C, Hugli T, Wykle R, McCall C, OFlaherty J . Anaphylactic actions of platelet-activating factor. Am J Pathol. 1981; 105(1):64-9. PMC: 1903854. View